Literature DB >> 28605659

Trimester-specific coagulation and anticoagulation reference intervals for healthy pregnancy.

Chanjuan Cui1, Shuo Yang2, Jie Zhang2, Guojing Wang1, Shengkai Huang1, Aiwei Li2, Yuncong Zhang2, Rui Qiao3.   

Abstract

BACKGROUND: Due to the normal physiological need of pregnancy and childbirth, the haemostatic system of pregnant women is different from that of healthy non-pregnant women. The aim of this study was to establish trimester-specific reference intervals of coagulation screening tests and thrombophilia markers in pregnancies without complications of females with Han ethnicity from North China.
METHODS: In total 744 Han healthy pregnant women (first trimester 207 cases, second trimester 222 cases and third trimester 315 cases) and 121 healthy non-pregnant women were recruited in North China. Eight tests-activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), fibrinogen (Fib), d-Dimer, antithrombin (AT), protein C (PC) and free protein S (fPS)-were processed on ACL TOP automated coagulation analyzer. The non-parametric 2.5th-97.5th percentiles reference intervals were calculated to establish trimester-specific reference intervals.
RESULTS: The reference intervals for APTT, PT, TT, Fib, d-Dimer, AT, PC, and fPS at first trimester were 26.4-41.9s, 9.7-12.5s, 11.7-17.0s, 2.38-4.44g/L, 0.01-0.31μg/mL, 72-120%, 29-150%, 21-143%, respectively. At second trimester, the reference intervals were 24.4-35.8s, 8.5-13.2s, 10.0-16.0s, 2.40-5.97g/L, 0.05-0.73μg/mL, 68-125%, 20-138%, 24-155%, respectively. At third trimester, the reference intervals were 25.6-34.9s, 8.6-12.4s, 11.1-15.5s, 2.79-5.91g/L, 0.14-2.82μg/mL, 56-119%, 20-134%, 17-140%, respectively. From the first trimester to the third trimester, APTT, PT and TT presented shortened trends, Fib and d-Dimer presented increasing trends, AT, PC and fPS activity presented decreasing trends, respectively.
CONCLUSIONS: The trimester-specific reference intervals of coagulation screening tests and thrombophilia markers in pregnancies without complications of females with Han ethnicity from North China are presented in this study, which may provide effective evidence for doctors to accurately diagnose and treat the disease during pregnancy.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anticoagulation; Coagulation; Pregnancy; Reference intervals

Mesh:

Year:  2017        PMID: 28605659     DOI: 10.1016/j.thromres.2017.05.021

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  11 in total

1.  Physiological changes of pregnancy and the Swansea criteria in diagnosing acute fatty liver of pregnancy.

Authors:  Adam Morton; Josephine Laurie
Journal:  Obstet Med       Date:  2018-04-16

2.  Prenatal Plasma Fibrinogen Level Predicts Postpartum Hemorrhage of Patients With HELLP Syndrome.

Authors:  Chanjuan Cui; Sisi Ma; Rui Qiao
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

3.  To Clot or Not: HELLP Syndrome and Disseminated Intravascular Coagulation in an Eclamptic Patient with Intrauterine Fetal Demise.

Authors:  Justin Walker; Anthony Bonavia
Journal:  Case Rep Anesthesiol       Date:  2020-07-07

4.  Reference Values of D-Dimers and Fibrinogen in the Course of Physiological Pregnancy: the Potential Impact of Selected Risk Factors-A Pilot Study.

Authors:  Aldona Siennicka; Magdalena Kłysz; Kornel Chełstowski; Aleksandra Tabaczniuk; Zuzanna Marcinowska; Paulina Tarnowska; Jolanta Kulesza; Andrzej Torbe; Maria Jastrzębska
Journal:  Biomed Res Int       Date:  2020-05-24       Impact factor: 3.411

5.  Changes in Coagulation During Twin Pregnancies.

Authors:  Ke Ren; Yuan Wei; Rui Qiao; Huifeng Shi; Xiaoli Gong; Yangyu Zhao
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

6.  Changes in levels of coagulation parameters in different trimesters among Chinese pregnant women.

Authors:  Wengong Wang; Kai Long; Fenglin Deng; Wei Ye; Pingwei Zhang; Xi Chen; Weiguo Dong; Ping Zheng; Xinxin Zhang; Tianyu Yang; Weihong Chen; Kai Yang
Journal:  J Clin Lab Anal       Date:  2021-02-05       Impact factor: 2.352

7.  Reference intervals for coagulation parameters in non-pregnant and pregnant women.

Authors:  Mengyu Fu; Junjie Liu; Jinfang Xing; Yanpeng Dai; Yanzi Ding; Kainan Dong; Xuewei Zhang; Enwu Yuan
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.996

8.  Association Between Pre-delivery Coagulation Indicators and Invasive Placenta Accreta Spectrum.

Authors:  Zhirong Guo; Xueyan Han; Huijing Zhang; Weiran Zheng; Huixia Yang; Jingmei Ma
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

9.  Coagulation tests and blood glucose before vaginal delivery in healthy teenage pregnant women compared with healthy adult pregnant women.

Authors:  Roxana Covali; Demetra Socolov; Razvan Socolov
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.889

10.  Position Statement on COVID-19 and Pregnancy in Women with Heart Disease Department of Women Cardiology of the Brazilian Society of Cardiology - 2020.

Authors:  Celi Marques-Santos; Walkiria Samuel Avila; Regina Coeli Marques de Carvalho; Alexandre Jorge Gomes de Lucena; Claudia Maria Vilas Freire; Elizabeth Regina Giunco Alexandre; Felipe Favorette Campanharo; Maria Alayde Mendonça R Rivera; Maria Elizabeth Navegantes Caetano Costa; Marildes Luiza de Castro
Journal:  Arq Bras Cardiol       Date:  2020-11       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.